Top Markets
#1 Seeker Seeker +134.41%
#2 AI XOVIA AI XOVIA +101.43%
#3 Helium Helium +70.37%
#4 MowCat MowCat +69.17%
#5 Pons Pons +40.95%
#6 UnifAI Network UnifAI Network +35.00%
#7 Zora Zora +29.90%
#8 Bounce Bounce +20.89%
#9 Zylo Ecosystem Zylo Ecosystem +20.85%
#10 TENDIES TENDIES +18.90%
Coin of the day
Seeker Seeker
Settings
Language
ENGLISH
Currency
USD
Theme
LanZhou Foci Pharmaceutical Co.,Ltd. LanZhou Foci Pharmaceutical Co.,Ltd.

LanZhou Foci Pharmaceutical Co.,Ltd.

002644
Rank in Stocks #11826
LanZhou Foci Pharmaceutical Co.,Ltd. is a prominent pharmaceutical entity based... LanZhou Foci Pharmaceutical Co.,Ltd. is a prominent pharmaceutical entity based in China, primarily focused on the manufacturing and distribution of traditional Chinese medicines. Its diverse product line, offered under the "Min Shan" and "Foci" brand names, encompasses a variety of formats, including pills, tablets, capsules, and granules. Beyond its production activities, the company actively pursues research and development initiatives aimed at pioneering novel herbal remedies. Its global footprint extends to approximately 27 countries, with key export markets including the United States, Canada, Japan, Australia, Russia, Ukraine, Singapore, Indonesia, Thailand, Malaysia, New Zealand, and Hong Kong. Established in 1929, the firm's headquarters are located in Lanzhou, China. LanZhou Foci Pharmaceutical Co.,Ltd. operates as a subsidiary of the Lanzhou Foci Pharmaceutical Factory.
Share Price
$1.28
Last synced: 2026-08-28
Market Cap
$654.17M
Change (1 day)
1.61%
Change (1 year)
0.38%
Country
CN
Trade LanZhou Foci Pharmaceutical Co.,Ltd. (002644)

Category

Healthcare
Revenue for LanZhou Foci Pharmaceutical Co.,Ltd. (002644)
Revenue in Aug 2026 TTM: 0
According to LanZhou Foci Pharmaceutical Co.,Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for LanZhou Foci Pharmaceutical Co.,Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN